What question did this study set out to answer?

The research aims to identify biomarkers associated with ANCA-associated glomerulonephritis (ANCA-GN) and elucidate their roles in disease progression.

February 13, 2026Open Access

Integrative transcriptomic and machine learning analysis identifies PYCARD and IFI30 as immune-lysosomal biomarkers of ANCA-associated glomerulonephritis

Key Points

The research aims to identify biomarkers associated with ANCA-associated glomerulonephritis (ANCA-GN) and elucidate their roles in disease progression.
Conducted transcriptomic analysis to identify candidate biomarkers
Employed machine learning algorithms to validate biomarker significance
Investigated mitophagy-immune interactions in disease progression
Found PYCARD and IFI30 as significant biomarkers for ANCA-GN
Demonstrated that mitophagy-immune crosstalk contributes to ANCA-GN progression
Provided insights into potential clinical targets for intervention

Abstract

These findings suggest that mitophagy-immune crosstalk drives ANCA-GN progression, with PYCARD and IFI30 as potential diagnostic biomarkers. This study provides mechanistic insights into ANCA-GN pathogenesis and proposes novel targets for clinical intervention.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Bei et al. (Tue,) studied this question.

synapsesocial.com/papers/698ebedd85a1ff6a93016380 https://doi.org/https://doi.org/10.1080/0886022x.2026.2624286

Bookmark

View Full Paper